We are live on ! Find out more
MAM

Mastrapasqua Asset Management Portfolio holdings

AUM $853M
1-Year Est. Return 37.36%
This Fund
S&P 500
This Quarter Est. Return
+7.81%
1 Year Est. Return
+37.36%
3 Year Est. Return
+54.87%
5 Year Est. Return
+127.67%
10 Year Est. Return
AUM
$408M
AUM Growth
+$31.1M
Cap. Flow
+$3.41M
Cap. Flow %
0.84%
Top 10 Hldgs %
22.32%
Holding
165
New
17
Increased
66
Reduced
62
Closed
13

Top Sells

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$5.53M
2
ESV
Ensco Rowan plc
ESV
+$5M
3
MCD icon
McDonald's
MCD
+$4.23M
4
ACN icon
Accenture
ACN
+$4.05M
5
ABBV icon
AbbVie
ABBV
+$2.99M

Sector Composition

Rank Sector Weight
1 Technology 18.44%
2 Industrials 15.33%
3 Healthcare 14.84%
4 Consumer Discretionary 13.19%
5 Financials 9.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMCSA icon
26
Comcast
CMCSA
$87.8B
$6.04M 1.48%
267,912
+5,512
+2% +$120K
MMM icon
27
3M
MMM
$93.9B
$5.88M 1.44%
58,936
+1,185
+2% +$115K
DD
28
DELISTED
Du Pont De Nemours E I
DD
$5.8M 1.42%
104,307
+1,357
+1% +$74.1K
NVS icon
29
Novartis
NVS
$294B
$5.76M 1.41%
83,807
+1,914
+2% +$127K
COV
30
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$5.47M 1.34%
89,752
-9,033
-9% -$551K
IBM icon
31
IBM
IBM
$222B
$5.4M 1.32%
30,496
+2,775
+10% +$504K
CVX icon
32
Chevron
CVX
$371B
$5.32M 1.3%
43,769
+1,635
+4% +$201K
BMY icon
33
Bristol-Myers Squibb
BMY
$130B
$5.09M 1.25%
109,995
+98,865
+888% +$4.34M
HON icon
34
Honeywell
HON
$78.6B
$5.08M 1.24%
68,075
-14,009
-17% -$1.04M
KLAC icon
35
KLA
KLAC
$252B
$4.93M 1.21%
810,400
+12,550
+2% +$73.6K
TMO icon
36
Thermo Fisher Scientific
TMO
$214B
$4.66M 1.14%
50,515
+1,484
+3% +$134K
UNP icon
37
Union Pacific
UNP
$176B
$4.63M 1.13%
59,564
+1,978
+3% +$156K
WMT icon
38
Walmart Inc
WMT
$894B
$4.59M 1.13%
+186,255
New +$4.7M
APC
39
DELISTED
Anadarko Petroleum
APC
$4.57M 1.12%
49,180
+443
+0.9% +$40.3K
BAX icon
40
Baxter International
BAX
$14.1B
$4.55M 1.11%
127,434
+8,231
+7% +$320K
FLR icon
41
Fluor
FLR
$7.04B
$4.38M 1.07%
61,758
+968
+2% +$62.8K
TROW icon
42
T. Rowe Price
TROW
$24.5B
$4.3M 1.05%
59,727
+4,089
+7% +$303K
MRSH
43
Marsh
MRSH
$91.4B
$4.11M 1.01%
94,410
+958
+1% +$40.3K
NTRS icon
44
Northern Trust
NTRS
$33.7B
$3.78M 0.93%
69,485
+961
+1% +$55.2K
ABT icon
45
Abbott
ABT
$183B
$3.76M 0.92%
113,394
-36,871
-25% -$1.29M
JPM icon
46
JPMorgan Chase
JPM
$955B
$3.72M 0.91%
+71,895
New +$3.86M
XOM icon
47
ExxonMobil
XOM
$628B
$3.67M 0.9%
42,653
-1,200
-3% -$108K
KDP icon
48
Keurig Dr Pepper
KDP
$41.8B
$3.62M 0.89%
80,660
+68,940
+588% +$3.17M
GILD icon
49
Gilead Sciences
GILD
$164B
$3.42M 0.84%
54,452
-3,344
-6% -$200K
NYX
50
DELISTED
NYSE EURONEXT INC
NYX
$3.19M 0.78%
+76,025
New +$3.19M

Similar funds

Mastrapasqua Asset Management's Q3 2013 Portfolio in Review

As of Q3 2013, Mastrapasqua Asset Management held 165 positions worth $408M, up 8.3% from $377M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Mastrapasqua Asset Management's Q3 2013 filing shows 17 new, 66 increased, 62 reduced and 13 closed positions. Its largest new stake was Walmart Inc: 186,255 shares worth $4.59M. The largest sale was Allergan Inc, an estimated $5.53M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Industrials and Healthcare.

  • Mastrapasqua Asset Management's largest Q3 2013 buy was Walmart Inc: 186,255 shares worth $4.59M.
  • Mastrapasqua Asset Management added most to Alphabet (Google) Class C in Q3 2013, an estimated $4.85M increase.
  • Mastrapasqua Asset Management's biggest Q3 2013 reduction was McDonald's, cutting an estimated $4.23M.
  • Mastrapasqua Asset Management fully exited Allergan Inc in Q3 2013, selling an estimated $5.53M.
  • Mastrapasqua Asset Management's ten largest holdings make up 22% of its $408M portfolio in Q3 2013.
  • Mastrapasqua Asset Management opened 17 new positions and closed 13 in Q3 2013.
  • Mastrapasqua Asset Management's portfolio value rose 8.3% quarter-over-quarter to $408M.

Based on Mastrapasqua Asset Management's 13F filing for Q3 2013, filed 14 Nov 2013.